Thousands to Walk Ahead for Brain Tumor Research Sunday
CINCINNATIOn Sunday, Oct. 25, more than 3,000 walkers and runners will pound the pavement in the sixth annual Walk Ahead for a Brain Tumor Cure. Already, the 2015 Walk Ahead has raised more than $276,000 for education and research at the Brain Tumor Center at the University of Cincinnati (UC) Neuroscience Institute and the UC Cancer Institute. The institutes are collaborations of the UC College of Medicine and UC Health.
Walk Ahead for a Brain Tumor Cure has raised more than $1.2 million for Cincinnati programs since its inception in 2010.
An estimated 215,000 brain tumors are diagnosed in the United States each year; of these, 45,000 have originated in the brain and 170,000 have metastasized from other parts of the body.
Patients, physicians and researchers of the UC Brain Tumor Center will be available for interviews before, during and after the Oct. 25 event.
Walk Ahead 5k Schedule
7 a.m.: Same-day registration opens
8 a.m.: Shotgun start for chip-timed 5K run, beginning at Yeatmans Cove, Sawyer Point
8:45 a.m.: Shotgun start for 5k walk, beginning at Yeatmans Cove, Sawyer Point
More information:
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.